Zeda Rosenberg, Chief Executive Offiver of the International Partnership for Microbicides, says: "While there is much progress to celebrate in HIV treatment and prevention, protecting women remains a major challenge. AIDS is the number-one killer of women ages 15 to 44 worldwide. Women are biologically more vulnerable to infection and face deep-rooted gender inequities that increase their risk. In sub-Saharan Africa, where the epidemic has taken the greatest toll, young women are at least twice as likely to contract HIV as young men."
26 November 2014 | Huffington Post
What do women want? While two trials test vaginal rings to fight HIV, market research highlights respondents’ interests in different options.
14 November 2014 | Science Speaks
On the heels of news that gay men had very high levels of protection from HIV infection through intermittent pre-exposure prophylaxis (PrEP) timed around sexual activity, a mathematical model predicts that most women would need to stick with a daily dose of Truvada (tenofovir/emtricitabine) to prevent HIV infection from vaginal sex.
12 November 2014 | The Body Pro
University of Washington researchers have created a discreet, quick-dissolving tampon out of silk-line fibers to protect women from HIV. The researchers would ideally like to develop a tampon to protect against HIV, herpes, and pregnancy — an all-in-one shield against the risks of sex. This could prove especially useful in developing countries, where women may not have easy access to other kinds of birth control.
04 November 2014 | Healthline News
The case was brought by three HIV-positive women who were subjected to sterilisation without their informed consent in public hospitals. The High Court found in favour of the women and held that the practice of coerced sterilisation violated the women’s legal rights.
04 November 2014 | Southern Africa Litigation Centre (press release)
A mathematical model developed by NIH grantees predicts that women must take the antiretroviral medication Truvada daily to prevent HIV infection via vaginal sex, whereas just two doses per week can protect men from HIV infection via anal sex. This finding helps explain why two large clinical trials testing HIV pre-exposure prophylaxis, or PrEP, in women failed to show efficacy
31 October 2014 | National Institute of Allergy and Infectious Diseases (NIAID) press release
“People around the world have mysterious notions about the vagina,” Sharon Hillier told a group of journalists and advocates today. Hillier, one of five co-chairs of HIV R4P, the first global conference devoted to biomedical HIV prevention research, is here to explain her work, which she sums up as making vaginas much more resistant to […](Read more...)
28 October 2014 | Science Speaks
Global literature and research shows that the relationship between violence against women and HIV risk is undeniable, complex and involves multiple pathways. Violence against women places women at an increased risk of HIV both through direct risk of infection and through creating an environment in which women are unable to adequately protect themselves from HIV...This involves chronically abusive relationships where women are repeatedly exposed to the same perpetrator.
26 October 2014 | Daily Ties, Pakistan
Many women addicted to drugs in Georgia are unable to access harm-reduction programmes because of stigma and discrimination, including from health professionals.
17 October 2014 | The Lancet
As Charlie Glickman, a sex educator and the author of The Ultimate Guide to Prostate Pleasure: Erotic Exploration of Men and their Partners, explained in an interview last year with Playboy: “We carry a lot of shame around our anuses. ... It’s a shame that starts when we’re in diapers.” According to Glickman,who identifies as bisexual, even as adults, “We look for a reason to justify the taboo. We say it’s disgusting. We say it’s dirty. We say it’s gross.”
14 October 2014 | The Guardian